| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
Accepted on ,
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction)
WRITING COMMITTEE MEMBERS ,
This article has been cited by other articles:
![]() |
E. J. Last and A. H. Sheehan Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors Am. J. Health Syst. Pharm., December 1, 2009; 66(23): 2117 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schindler New players in the field of antiplatelet and anticoagulant therapy in coronary heart disease - current therapeutic issues and hot topics Therapeutic Advances in Cardiovascular Disease, December 1, 2009; 3(6): 413 - 421. [PDF] |
||||
![]() |
D. Domanski and E. R. Schwarz Clinical Review: Is the Perioperative Use of {beta}-Blockers Still Recommended? A Critical Review of Recent Controversies Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 258 - 268. [Abstract] [PDF] |
||||
![]() |
G. Montalescot, H. Drexler, R. Gallo, T. Pearson, M. Thoenes, and D. L. Bhatt Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study Eur. Heart J., November 2, 2009; 30(22): 2733 - 2741. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Danner, V. N. Didilis, T. Stojanovic, A. Popov, M. Grossmann, R. Seipelt, and F. A. Schondube A three-group model to predict mortality in emergent coronary artery bypass graft surgery. Ann. Thorac. Surg., November 1, 2009; 88(5): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montalescot, R. Gallo, H. D. White, M. Cohen, Ph. G. Steg, P. E.G. Aylward, C. Bode, M. Chiariello, S. B. King III, R. A. Harrington, et al. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention: 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial J. Am. Coll. Cardiol. Intv., November 1, 2009; 2(11): 1083 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kaski C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it? Eur. Heart J., October 23, 2009; (2009) ehp435v1. [Full Text] [PDF] |
||||
![]() |
S. F. Aranki and S. C. Body Antiplatelet agents used for early intervention in acute coronary syndrome: Myocardial salvage versus bleeding complications. J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 807 - 810.e7. [Full Text] [PDF] |
||||
![]() |
G. Montalescot, D. Brieger, K. A. Eagle, F. A. Anderson Jr, G. FitzGerald, M. S. Lee, Ph. G. Steg, A. Avezum, S. G. Goodman, J. M. Gore, et al. Unprotected left main revascularization in patients with acute coronary syndromes Eur. Heart J., October 1, 2009; 30(19): 2308 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bangalore, F. H. Messerli, F.-S. Ou, J. Tamis-Holland, A. Palazzo, M. T. Roe, M. K. Hong, E. D. Peterson, and for the CRUSADE Investigators The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes: results from 135 164 patients in the CRUSADE quality improvement initiative Eur. Heart J., September 30, 2009; (2009) ehp397v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K-R Chiou, W-C Huang, N-J Peng, Y-L Huang, S-H Hsiao, K-H Chen, and M-T Wu Dual-phase multi-detector computed tomography assesses jeopardised and infarcted myocardium subtending infarct-related artery early after acute myocardial infarction Heart, September 15, 2009; 95(18): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wallentin, R. C. Becker, A. Budaj, C. P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, et al. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes N. Engl. J. Med., September 10, 2009; 361(11): 1045 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Szummer, P. Lundman, S. H. Jacobson, S. Schon, J. Lindback, U. Stenestrand, L. Wallentin, T. Jernberg, and for SWEDEHEART Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction: Data From the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) Circulation, September 8, 2009; 120(10): 851 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montalescot, G. Cayla, J.-P. Collet, S. Elhadad, F. Beygui, H. Le Breton, R. Choussat, F. Leclercq, J. Silvain, F. Duclos, et al. Immediate vs Delayed Intervention for Acute Coronary Syndromes: A Randomized Clinical Trial JAMA, September 2, 2009; 302(9): 947 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reichlin, W. Hochholzer, S. Bassetti, S. Steuer, C. Stelzig, S. Hartwiger, S. Biedert, N. Schaub, C. Buerge, M. Potocki, et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays N. Engl. J. Med., August 27, 2009; 361(9): 858 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Damman, J. Tijssen, R. de Winter, B. Rathod, A. Cequier, J. A. Gomez-Hospital, J. Gonzalez-Costello, S. Shojai, S. R. Mehta, S. Yusuf, et al. Acute Coronary Syndromes N. Engl. J. Med., August 27, 2009; 361(9): 925 - 927. [Full Text] [PDF] |
||||
![]() |
L. Wallentin P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use Eur. Heart J., August 2, 2009; 30(16): 1964 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Califf Angiographic Profiles in Courage Circ Cardiovasc Qual Outcomes, July 1, 2009; 2(4): 292 - 293. [Full Text] [PDF] |
||||
![]() |
M. Y. Chan, J. L. Sun, L. K. Newby, L. K. Shaw, M. Lin, E. D. Peterson, R. M. Califf, D. F. Kong, and M. T. Roe Long-Term Mortality of Patients Undergoing Cardiac Catheterization for ST-Elevation and Non-ST-Elevation Myocardial Infarction Circulation, June 23, 2009; 119(24): 3110 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Brieger, K A A Fox, G FitzGerald, K A Eagle, A Budaj, A Avezum, C B Granger, B Costa, F A Anderson Jr, P. G Steg, et al. Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events Heart, June 1, 2009; 95(11): 888 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hillis and R. A. Lange Optimal Management of Acute Coronary Syndromes N. Engl. J. Med., May 21, 2009; 360(21): 2237 - 2240. [Full Text] [PDF] |
||||
![]() |
J. L. Mega, S. L. Close, S. D. Wiviott, L. Shen, R. D. Hockett, J. T. Brandt, J. R. Walker, E. M. Antman, W. L. Macias, E. Braunwald, et al. Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes Circulation, May 19, 2009; 119(19): 2553 - 2560. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hoffmann and F. Bamberg Is Computed Tomography Coronary Angiography the Most Accurate and Effective Noninvasive Imaging Tool to Evaluate Patients With Acute Chest Pain in the Emergency Department?: CT Coronary Angiography Is the Most Accurate and Effective Noninvasive Imaging Tool for Evaluating Patients Presenting With Chest Pain to the Emergency Department Circ Cardiovasc Imaging, May 1, 2009; 2(3): 251 - 263. [Full Text] [PDF] |
||||
![]() |
M. Kosiborod, S. E. Inzucchi, A. Goyal, H. M. Krumholz, F. A. Masoudi, L. Xiao, and J. A. Spertus Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction JAMA, April 15, 2009; 301(15): 1556 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chua and A. Ignaszewski Clopidogrel in acute coronary syndromes BMJ, April 14, 2009; 338(apr14_1): b1180 - b1180. [Full Text] |
||||
![]() |
J. L. Anderson Stopping the Hemorrhage: A New Baseline Bleeding Score Brings Us a Step Closer for Patients With Non-ST-Elevation Myocardial Infarction Circulation, April 14, 2009; 119(14): 1846 - 1849. [Full Text] [PDF] |
||||
![]() |
M. Kosiborod, S. E. Inzucchi, J. A. Spertus, Y. Wang, F. A. Masoudi, E. P. Havranek, and H. M. Krumholz Elevated Admission Glucose and Mortality in Elderly Patients Hospitalized With Heart Failure Circulation, April 14, 2009; 119(14): 1899 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sourgounis, J. Lipiecki, T. S. Lo, and M. Hamon Coronary Stents and Chronic Anticoagulation Circulation, March 31, 2009; 119(12): 1682 - 1688. [Full Text] [PDF] |
||||
![]() |
E. M. Antman and E. D. Peterson Tools for Guiding Clinical Practice From the American Heart Association and the American College of Cardiology: What Are They and How Should Clinicians Use Them? Circulation, March 10, 2009; 119(9): 1180 - 1185. [Full Text] [PDF] |
||||
![]() |
S. Cheng, D. A. Morrow, S. Sloan, E. M. Antman, and M. S. Sabatine Predictors of Initial Nontherapeutic Anticoagulation With Unfractionated Heparin in ST-Segment Elevation Myocardial Infarction Circulation, March 10, 2009; 119(9): 1195 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kosiborod, S. E. Inzucchi, H. M. Krumholz, F. A. Masoudi, A. Goyal, L. Xiao, P. G. Jones, S. Fiske, and J. A. Spertus Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction Arch Intern Med, March 9, 2009; 169(5): 438 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Berger, D. L. Brown, G. L. Burke, A. Oberman, J. B. Kostis, R. D. Langer, N. D. Wong, and S. Wassertheil-Smoller Aspirin Use, Dose, and Clinical Outcomes in Postmenopausal Women With Stable Cardiovascular Disease: The Women's Health Initiative Observational Study Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yan, R. T. Yan, T. Huynh, A. Casanova, F. E. Raimondo, D. H. Fitchett, A. Langer, S. G. Goodman, and for the Canadian Acute Coronary Syndrome Registry Understanding Physicians' Risk Stratification of Acute Coronary Syndromes: Insights From the Canadian ACS 2 Registry Arch Intern Med, February 23, 2009; 169(4): 372 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aoki, A. J. Lansky, R. Mehran, J. Moses, M. E. Bertrand, B. T. McLaurin, D. A. Cox, A. M. Lincoff, E. M. Ohman, H. D. White, et al. Early Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Drug-Eluting and Bare Metal Stents: The Acute Catheterization and Urgent Intervention Triage Strategy Trial Circulation, February 10, 2009; 119(5): 687 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Jacobs Coronary Intervention in 2009: Are Women No Different Than Men? Circ Cardiovasc Interv, February 1, 2009; 2(1): 69 - 78. [Full Text] [PDF] |
||||
![]() |
T. Simon, C. Verstuyft, M. Mary-Krause, L. Quteineh, E. Drouet, N. Meneveau, P. G. Steg, J. Ferrieres, N. Danchin, L. Becquemont, et al. Genetic Determinants of Response to Clopidogrel and Cardiovascular Events N. Engl. J. Med., January 22, 2009; 360(4): 363 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Heinrich, L. Haberle, V. Muller, W. Bautz, and M. Uder Nephrotoxicity of Iso-osmolar Iodixanol Compared with Nonionic Low-osmolar Contrast Media: Meta-analysis of Randomized Controlled Trials Radiology, January 1, 2009; 250(1): 68 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Adams Jr Secondary Prevention of Atherothrombotic Events After Ischemic Stroke Mayo Clin. Proc., January 1, 2009; 84(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jneid, G. C. Fonarow, C. P. Cannon, A. F. Hernandez, I. F. Palacios, A. O. Maree, Q. Wells, B. Bozkurt, K. A. LaBresh, L. Liang, et al. Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction Circulation, December 16, 2008; 118(25): 2803 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. MacNee, J. Maclay, and D. McAllister Cardiovascular Injury and Repair in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2008; 5(8): 824 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Lincoff, S. R. Steinhubl, S. V. Manoukian, D. Chew, C. V. Pollack Jr, F. Feit, J. H. Ware, M. E. Bertrand, E. M. Ohman, W. Desmet, et al. Influence of Timing of Clopidogrel Treatment on the Efficacy and Safety of Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial J. Am. Coll. Cardiol. Intv., December 1, 2008; 1(6): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Eggers, L. Wallentin, and K. C. Wollert Growth-differentiation factor-15 for risk stratification in patients with acute chest pain: reply Eur. Heart J., December 1, 2008; 29(23): 2947 - 2948. [Full Text] [PDF] |
||||
![]() |
M. Y. Chan, F. Andreotti, and R. C. Becker Hypercoagulable States in Cardiovascular Disease Circulation, November 25, 2008; 118(22): 2286 - 2297. [Full Text] [PDF] |
||||
![]() |
A. K. Saenger and A. S. Jaffe Requiem for a Heavyweight: The Demise of Creatine Kinase-MB Circulation, November 18, 2008; 118(21): 2200 - 2206. [Full Text] [PDF] |
||||
![]() |
T. Y. Wang, L. Xiao, K. P. Alexander, S. V. Rao, M. N. Kosiborod, J. S. Rumsfeld, J. A. Spertus, and E. D. Peterson Antiplatelet Therapy Use After Discharge Among Acute Myocardial Infarction Patients With In-Hospital Bleeding Circulation, November 18, 2008; 118(21): 2139 - 2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Mehta, W. E. Boden, J. W. Eikelboom, M. Flather, P. G. Steg, A. Avezum, R. Afzal, L. S. Piegas, D. P. Faxon, P. Widimsky, et al. Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non-ST-Segment Elevation Acute Coronary Syndromes: An Individual Patient-Level Combined Analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) Randomized Trials Circulation, November 11, 2008; 118(20): 2038 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Jeger, D. Radovanovic, P. R. Hunziker, M. E. Pfisterer, J.-C. Stauffer, P. Erne, P. Urban, and for the AMIS Plus Registry Investigators Ten-Year Trends in the Incidence and Treatment of Cardiogenic Shock Ann Intern Med, November 4, 2008; 149(9): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Arnold, D. A. Morrow, K. Wang, Y. Lei, E. M. Mahoney, B. M. Scirica, E. Braunwald, D. J. Cohen, and on behalf of the MERLIN-TIMI 36 Investigators Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Steg, A. Kerner, F. Van de Werf, J. Lopez-Sendon, J. M. Gore, G. FitzGerald, L. J. Feldman, F. A. Anderson, A. Avezum, and for the Global Registry of Acute Coronary Events ( Impact of In-Hospital Revascularization on Survival in Patients With Non-ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure Circulation, September 9, 2008; 118(11): 1163 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nickel, T. Kempf, H. Tapken, J. Tongers, F. Laenger, U. Lehmann, H. Golpon, K. Olsson, M. R. Wilkins, J. S. R. Gibbs, et al. Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 534 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe Key Issues in the Developing Synergism between Cardiovascular Imaging and Biomarkers Clin. Chem., September 1, 2008; 54(9): 1432 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cavender and E. M. Ohman What Do You Need to Know Before Performing a Percutaneous Coronary Intervention? Circulation, August 5, 2008; 118(6): 609 - 611. [Full Text] [PDF] |
||||
![]() |
D. W. Jones, E. D. Peterson, R. O. Bonow, F. A. Masoudi, G. C. Fonarow, S. C. Smith Jr, P. Solis, M. Girgus, P. C. Hinton, A. Leonard, et al. Translating Research Into Practice for Healthcare Providers: The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke Circulation, August 5, 2008; 118(6): 687 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Antman and D. A. Morrow Biomarker Release After Percutaneous Coronary Intervention: A Message From the Heart Circ Cardiovasc Interv, August 1, 2008; 1(1): 3 - 6. [Full Text] [PDF] |
||||
![]() |
C D Miller, G J Fermann, C J Lindsell, K W Mahaffey, W F Peacock, C V Pollack, J E Hollander, D B Diercks, W B Gibler, and J W Hoekstra on behalf of the EMCREG-International Initial risk stratification and presenting characteristics of patients with evolving myocardial infarctions Emerg. Med. J., August 1, 2008; 25(8): 492 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Baldazzi, E. Jorgensen, R. S. Ripa, and J. Kastrup Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route Eur. Heart J., August 1, 2008; 29(15): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Haines Introduction Am. J. Health Syst. Pharm., August 1, 2008; 65(15_Supplement_7): S3 - S4. [Full Text] [PDF] |
||||
![]() |
K. W. Phillips, P. P. Dobesh, and S. T. Haines Considerations in using anticoagulant therapy in special patient populations Am. J. Health Syst. Pharm., August 1, 2008; 65(15_Supplement_7): S13 - S21. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Dobesh, K. W. Phillips, and S. T. Haines Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome Am. J. Health Syst. Pharm., August 1, 2008; 65(15_Supplement_7): S22 - S28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Chan, M. G. Cohen, C. K. Dyke, S. K. Myles, L. G. Aberle, M. Lin, J. Walder, S. R. Steinhubl, I. C. Gilchrist, N. S. Kleiman, et al. Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease Circulation, June 3, 2008; 117(22): 2865 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Gellatly and M. L Ackman Single Antiplatelet Therapy for Patients with Previous Gastrointestinal Bleeds Ann. Pharmacother., June 1, 2008; 42(6): 836 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J. Hermosillo and S. A Spinler Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous? Ann. Pharmacother., June 1, 2008; 42(6): 790 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Patrono, C. Baigent, J. Hirsh, and G. Roth Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 199S - 233S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Spiel, J. C. Gilbert, and B. Jilma Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes Circulation, March 18, 2008; 117(11): 1449 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Daugherty, P. M. Ho, J. A. Spertus, P. G. Jones, R. G. Bach, H. M. Krumholz, E. D. Peterson, J. S. Rumsfeld, and F. A. Masoudi Association of Early Follow-up After Acute Myocardial Infarction With Higher Rates of Medication Use Arch Intern Med, March 10, 2008; 168(5): 485 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Qayyum, M. R. Khalid, J. Adomaityte, S. P. Papadakos, and F. C. Messineo Systematic Review: Comparing Routine and Selective Invasive Strategies for the Acute Coronary Syndrome Ann Intern Med, February 5, 2008; 148(3): 186 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Stone, J. H. Ware, M. E. Bertrand, A. M. Lincoff, J. W. Moses, E. M. Ohman, H. D. White, F. Feit, A. Colombo, B. T. McLaurin, et al. Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management: One-Year Results From the ACUITY Trial JAMA, December 5, 2007; 298(21): 2497 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Page II, K. J Utz, and E. E Wolfel Should {beta}-Blockers Be Used in the Treatment of Cocaine-Associated Acute Coronary Syndrome? Ann. Pharmacother., December 1, 2007; 41(12): 2008 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wollert, T. Kempf, B. Lagerqvist, B. Lindahl, S. Olofsson, T. Allhoff, T. Peter, A. Siegbahn, P. Venge, H. Drexler, et al. Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome Circulation, October 2, 2007; 116(14): 1540 - 1548. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |